IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Decheng Capital Management III (Cayman), LLC

Q2 2023 Holdings

Filed 2023-07-28 | 25 holdings | $318.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alpine Immune Sciences, Inc.COM010392595$69.0M6,708,28821.6%
Zentalis Pharmaceuticals Inc.(ZNTL)COM98943L107$59.2M2,099,58318.6%
Acelyrin Inc(nsm)COM00445A100$32.5M1,554,41710.2%
10x Genomics, Inc.(TXG)CL A COM88025U109$20.1M359,5546.3%
Pacific Biosciences of California, Inc.(PACB)COM69404D108$19.5M1,463,8726.1%
Arcus BioSciences, Inc.(RCUS)COM03969F109$17.7M869,7905.5%
Illumnia, Inc.(ILMN)COM452327109$15.2M80,8594.8%
Roivant Sciences LTDCOM00BMW4NZ9$14.7M1,459,7004.6%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$12.2M850,0003.8%
Argenx SE(ARGX)SHS04016X101$10.7M27,4293.4%
Horizon Therapeutics PLCCOMG46188101$8.1M78,9002.5%
Terns Pharmaceuticals, Inc.(TERN)COM880881107$6.2M714,2852.0%
BeyondSpring Inc.SHS00BD36JB9$5.9M4,958,1431.8%
Seagen Inc.COM812578102$4.4M23,0141.4%
Aura Biosciences, Inc.(AURA)COM05153U107$3.6M293,3331.1%
Aadi Bioscience, Inc.(WHWK)COM00032Q104$3.6M526,3291.1%
Equillium Inc.(EQ)COM29446K106$3.3M4,447,3081.0%
Cue Health Inc.(HLTHQ)COM229790100$3.3M8,980,9091.0%
Mersana Therapeutics, Inc.COM59045L106$3.0M904,2680.9%
AtriCure Inc.COM004963C20$2.3M46,2590.7%
Scynexis Inc.(SCYX)COM NEW811292200$1.6M555,5550.5%
Adicet Bio, Inc.(TORCEUR)COM007002108$1.2M505,6680.4%
Apexigen, Inc.COM03759B102$814.3K1,894,5510.3%
GeneDx Holdings Corp.(SMFRUSD)COM CL A81663L101$617.5K103,6040.2%
NeuBase Therapeutics, Inc.COM64132K102$92.5K50,0000.0%